ICU Medical, Inc. (NASDAQ:ICUI) updated its FY17 earnings guidance on Wednesday. The company provided earnings per share guidance of $3.80-4.20 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.14.
Several research firms recently weighed in on ICUI. Zacks Investment Research downgraded ICU Medical from a buy rating to a hold rating in a research report on Friday, July 14th. Sidoti downgraded ICU Medical from a buy rating to a neutral rating in a research report on Tuesday, June 20th. BidaskClub downgraded ICU Medical from a hold rating to a sell rating in a research report on Wednesday, August 9th. Finally, Roth Capital downgraded ICU Medical from a buy rating to a neutral rating in a research report on Thursday, May 11th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. The company has a consensus rating of Hold and an average target price of $193.00.
ICU Medical, Inc. (NASDAQ ICUI) traded down 0.41% during trading on Friday, reaching $169.30. The company had a trading volume of 73,333 shares. The stock has a 50 day moving average price of $171.58 and a 200 day moving average price of $159.92. The firm has a market capitalization of $3.36 billion, a P/E ratio of 67.80 and a beta of 0.37. ICU Medical, Inc. has a 52 week low of $120.15 and a 52 week high of $176.50.
ICU Medical (NASDAQ:ICUI) last posted its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the Zacks’ consensus estimate of $0.58 by $0.06. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business had revenue of $331.51 million for the quarter, compared to analyst estimates of $318.30 million. During the same quarter last year, the business earned $1.15 earnings per share. ICU Medical’s revenue was up 242.8% on a year-over-year basis. Analysts predict that ICU Medical, Inc. will post $4.11 earnings per share for the current year.
In related news, Director Robert S. Swinney sold 4,477 shares of the firm’s stock in a transaction dated Thursday, July 20th. The shares were sold at an average price of $175.00, for a total value of $783,475.00. Following the transaction, the director now directly owns 23,293 shares of the company’s stock, valued at approximately $4,076,275. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Vivek Jain sold 3,704 shares of the firm’s stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $171.00, for a total transaction of $633,384.00. Following the completion of the transaction, the chief executive officer now directly owns 110,925 shares in the company, valued at $18,968,175. The disclosure for this sale can be found here. Insiders have sold a total of 203,965 shares of company stock worth $34,856,920 over the last 90 days. Insiders own 15.90% of the company’s stock.
WARNING: “ICU Medical, Inc. (NASDAQ:ICUI) Releases FY17 Earnings Guidance” was first published by BNB Daily and is the property of of BNB Daily. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/icu-medical-inc-nasdaqicui-updates-fy17-earnings-guidance-updated.html.
About ICU Medical
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.